THE MOSAIC COMPANY REPORTS SECOND QUARTER 2026 RESULTS

The Mosaic Company Reports Second Quarter 2026 Results

Navigating Challenging Market Conditions Through Strategic Cost Reductions and Production Discipline

TAMPA, FL — August 4, 2026

The Mosaic Company (NYSE: MOS) reported its second quarter 2026 results[cite: 1], posting net sales of $2.8 billion[cite: 1], an operating loss of $36 million[cite: 1], and a net loss of $273 million[cite: 1] (or $0.86 per share[cite: 1]). Excluding notable items, adjusted EBITDA totaled $407 million[cite: 1] and adjusted diluted earnings per share reached $0.13.

Executive Commentary and Market Pressures

President and CEO Bruce Bodine noted that business conditions during the quarter remained challenging, driven primarily by sulfur availability and affordability issues[cite: 1].

“At Mosaic, we are focused on the things we can control. We’ve reduced phosphate production, cut costs, reduced capital expenditures and strengthened our financial flexibility while maintaining the ability to resume full production rates when markets improve.”

— Bruce Bodine, President and CEO

Second Quarter Segment Performance

  • Phosphates: Sales volumes reached 1.4 million tonnes[cite: 1]. The segment reported an operating loss of $104 million[cite: 1] and adjusted EBITDA of $128 million[cite: 1], impacted by higher raw material costs and reduced fixed-cost absorption from lower operating rates. Third-quarter sulfur contracts were settled at $705 per long ton[cite: 1].
  • Potash: Sales volumes totaled 2.0 million tonnes[cite: 1]. Operating earnings were $195 million[cite: 1] with an adjusted EBITDA of $278 million[cite: 1], reflecting balanced market fundamentals and strong demand across major consuming regions.
  • Mosaic Fertilizantes: Sales volumes reached 1.5 million tonnes[cite: 1]. The segment posted an operating loss of $41 million[cite: 1] and adjusted EBITDA of $60 million[cite: 1], driven by soft domestic demand and curtailed commodity production due to sulfur challenges.
  • Mosaic Biosciences: Delivered net sales of $25 million in Q2, continuing on track to double 2025’s total annual sales of $68 million.

Guidance and Capital Allocation Updates

In response to market dynamics, Mosaic has trimmed its full-year 2026 capital expenditures outlook down to $1.2 billion[cite: 1] (from $1.25 billion previously). SG&A expenses are expected to range between $510 and $530 million, while full-year Potash production is projected at approximately 9.0 million tonnes.

“Building resilient and productive food systems for the future through essential crop nutrients and biological innovation.”

© 2026 The Mosaic Company | Q2 2026 Financial Results & Earnings Overview[cite: 1]

Leave a Reply

Your email address will not be published. Required fields are marked *


View More →